Expanding Options, Lingering Questions: How to Select the Right Immunotherapy for First-Line Treatment of Advanced NSCLC |
09/23/2022 - 8:00am to 9:00am EDT |
CLL and Autoimmune Hemolytic Anemia |
09/30/2022 - 8:00am to 9:00am EDT |
Waldenstrom's Macroglobulinemia and Amyloidosis |
10/07/2022 - 8:00am to 9:00am EDT |
Expanding the Use of TKIs/Pathway Inhibitors for Patients with Neuroendocrine Neoplasms |
10/14/2022 - 8:00am to 9:00am EDT |
How to Harness Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HR2- Early Breast Cancer: New Goals and Better Tools to Close the Gaps |
10/21/2022 - 8:00am to 9:00am EDT |
Leiomyosarcoma: A Challenging Case and Literature Review |
10/28/2022 - 8:00am to 9:00am EDT |
Creating a Roadmap for Modern Prostate Cancer Treatment |
11/04/2022 - 8:00am to 9:00am EDT |
Early T Cell Precursor ALL: A high risk type of leukemia |
11/11/2022 - 8:00am to 9:00am EST |
Ovarian Cancer |
11/18/2022 - 8:00am to 9:00am EST |
All Oral Adjuvant Chemotherapy Regimen, CMC, for Early-Stage Breast Cancer: What’s Old is New |
12/02/2022 - 8:00am to 9:00am EST |